COLETTE BLANCHARD: Open Payments
NPI 1104814961 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 25 payments from 13 companies in 2025. Trend: 2023 $635 · 2024 $1,174 · 2025 $1,203
Food & beverage: $1,104Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $247 |
| Janssen Biotech, Inc. | 1 | $146 |
| Phathom Pharmaceuticals, Inc. | 1 | $124 |
| Sage Therapeutics, LLC | 2 | $121 |
| KYOWA KIRIN, INC. | 1 | $118 |
| Biogen, Inc. | 1 | $100 |
| Lilly USA, LLC | 1 | $87 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $78 |
| Sumitomo Pharma America, Inc. | 1 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
Products named: Veozah, VOQUEZNA, ZURZUVAE, ZEPBOUND, MYFEMBREE, Lynkuet, Dexcom G6 Transmitter, Exparel.
Industry payments across LA — which companies pay providers there.
